Your browser is no longer supported. Please, upgrade your browser.
Settings
NVCN Neovasc Inc. daily Stock Chart
NVCN [NASD]
Neovasc Inc.
Index- P/E- EPS (ttm)-7.63 Insider Own7.84% Shs Outstand24.98M Perf Week12.59%
Market Cap11.95M Forward P/E- EPS next Y-0.13 Insider Trans0.00% Shs Float- Perf Month16.06%
Income- PEG- EPS next Q-0.05 Inst Own4.64% Short Float- Perf Quarter-42.35%
Sales1.75M P/S6.83 EPS this Y79.70% Inst Trans- Short Ratio0.57 Perf Half Y-78.25%
Book/sh-0.35 P/B- EPS next Y50.00% ROA- Target Price1.88 Perf Year-90.23%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.37 - 5.14 Perf YTD-20.65%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-90.69% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low28.63% ATR0.05
Employees98 Current Ratio- Sales Q/Q-57.40% Oper. Margin- RSI (14)50.28 Volatility18.37% 10.17%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.70 Prev Close0.50
ShortableYes LT Debt/Eq- EarningsMar 21 AMC Payout- Avg Volume2.01M Price0.48
Recom1.00 SMA209.25% SMA50-6.00% SMA200-72.58% Volume1,426,595 Change-3.33%
Jan-19-18Resumed Canaccord Genuity Buy $1.05
Apr-05-17Upgrade Ladenburg Thalmann Neutral → Buy
May-20-16Downgrade Ladenburg Thalmann Buy → Neutral
Dec-10-15Initiated Ladenburg Thalmann Buy $9.25
Oct-07-15Resumed JMP Securities Mkt Outperform
Apr-02-15Initiated Canaccord Genuity Buy $15
Mar-31-15Initiated Northland Capital Outperform $12
Apr-17-19 03:42PM  Neovasc Announces Resolution of Last Remaining Active Litigation CNW Group +31.16%
07:50AM  Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer Improves Diastolic Function in patients suffering from severe angina PR Newswire
Mar-21-19 05:08PM  Neovasc: 4Q Earnings Snapshot Associated Press
04:01PM  Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
04:01PM  Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results CNW Group
07:50AM  Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara PR Newswire
Mar-19-19 07:50AM  Reducer Featured in Presentation at American College of Cardiology's Annual Meeting PR Newswire
07:50AM  Reducer Featured in Presentation at American College of Cardiology's Annual Meeting CNW Group
Mar-15-19 02:30PM  Neovasc Announces Closing of $5 Million Public Offering of Common Shares PR Newswire
02:30PM  Neovasc Announces Closing of $5 Million Public Offering of Common Shares CNW Group
Mar-14-19 04:01PM  Neovasc Completes Successful Quality System Surveillance Audit PR Newswire
Mar-13-19 04:30PM  Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21 PR Newswire -9.75%
04:30PM  Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21 CNW Group
07:27AM  The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga
06:20AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares PR Newswire
06:20AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares CNW Group
Mar-12-19 04:01PM  Neovasc Announces Proposed Public Offering of Common Shares CNW Group
09:15AM  Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares PR Newswire
09:15AM  Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares CNW Group
Mar-05-19 03:45PM  Neovasc Announces Reducer Implant "Live Case" at the CRT Meeting in Washington, DC PR Newswire +14.71%
03:45PM  Neovasc Announces Reducer Implant "Live Case" at the CRT Meeting in Washington, DC CNW Group
Mar-04-19 01:00PM  Neovasc's Tiara Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting CNW Group
Feb-28-19 02:55PM  Neovasc announces closing of $5 million public offering of common shares CNW Group +17.50%
Feb-27-19 04:30PM  Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference CNW Group
Feb-26-19 06:00AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares PR Newswire -28.59%
06:00AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares CNW Group
Feb-25-19 04:01PM  Neovasc Announces Proposed Public Offering of Common Shares CNW Group
Feb-22-19 05:30PM  Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018 CNW Group
Feb-21-19 07:30AM  Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World PR Newswire
Feb-20-19 07:30AM  Neovasc Provides Corporate Update CNW Group
Feb-11-19 07:30AM  Pierangeli Clinic Initiates Program Providing Neovasc Reducer Procedure to Italian Patients with Refractory Angina CNW Group
Jan-30-19 07:30AM  Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina CNW Group
Jan-29-19 02:30PM  These 4 Healthcare Stocks Healthy With Potential Opportunities ACCESSWIRE +13.54%
07:30AM  Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK PR Newswire
07:30AM  Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK CNW Group
Jan-23-19 09:45AM  4 Healthcare Stocks Making Moves On Wednesday (1/23/19) ACCESSWIRE
08:05AM  Neovasc, Litigation Information and Product Reviews ACCESSWIRE
07:30AM  Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation CNW Group
Jan-22-19 09:25AM  4 Healthcare Stocks Looking to Set the Pace on Tuesday (1/22/19) ACCESSWIRE +10.43%
07:30AM  Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences CNW Group
Jan-14-19 04:30PM  Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency CNW Group
Jan-03-19 07:14PM  Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency PR Newswire
07:14PM  Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency CNW Group
Dec-21-18 03:15PM  Neovasc Receives ISO 13485: 2016 Certification CNW Group +27.21%
Dec-11-18 07:30AM  Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer as Published in JACC PR Newswire
Nov-20-18 07:30AM  JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer Patient Case PR Newswire -8.80%
Nov-15-18 07:00AM  Today's Research Reports on Trending Tickers: Neovasc and Acadia Healthcare ACCESSWIRE -18.44%
Nov-14-18 07:40PM  Neovasc: 3Q Earnings Snapshot Associated Press
04:00PM  Neovasc Announces Third Quarter 2018 Financial Results PR Newswire
04:00PM  Neovasc Announces Third Quarter 2018 Financial Results CNW Group
08:03AM  Neovasc Q3 Earnings Preview Benzinga
Nov-07-18 07:30AM  Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast PR Newswire
07:30AM  Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast CNW Group
Oct-23-18 11:30AM  3 Healthcare Stocks To Watch On Tuesday ACCESSWIRE +5.13%
10:43AM  Neovasc Broadcasts Surgery With Mitral Valve Device Live At Medical Conference Benzinga
Oct-22-18 04:30PM  Neovasc Announces Successful Tiara "Live Case" at the 32nd Annual EACTS 2018 Meeting PR Newswire -11.36%
Oct-16-18 07:30AM  Neovasc Announces Publication of a Peer-Reviewed Article on Tiara Cases in Circulation: Cardiovascular Interventions CNW Group
Oct-11-18 08:00AM  Todays Research Reports on Stocks to Watch: Neovasc and AcelRx Pharmaceuticals ACCESSWIRE
Oct-10-18 03:23PM  Why Neovasc Stock (NVCN) Is Skyrocketing Today InvestorPlace +14.75%
10:41AM  Neovasc's stock rockets after 'Reducer' granted Breakthrough Device designation MarketWatch
07:30AM  Neovasc Reducer Granted Breakthrough Device Designation from FDA PR Newswire
Oct-09-18 02:05PM  Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule PR Newswire -7.58%
Oct-03-18 08:28AM  Neovasc shares soar 24% on news of positive data from first U.S. patient to use device to treat angina MarketWatch +18.67%
07:30AM  Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer PR Newswire
Sep-27-18 08:43AM  Neovasc (NVCN) Looks Good: Stock Adds 7.4% in Session Zacks
Sep-24-18 08:00AM  Today's Research Reports on Trending Tickers: TransEnterix and Neovasc ACCESSWIRE
Sep-20-18 07:30AM  Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference CNW Group
Sep-19-18 10:20AM  Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany PR Newswire +8.91%
Sep-18-18 06:00PM  Neovasc Announces Effective Date of Share Consolidation PR Newswire +5.56%
Sep-12-18 07:30AM  Neovasc Announces Amendments to Outstanding Convertible Notes, including 1-Year Extension of Note Maturity Date PR Newswire
07:30AM  Neovasc Announces Amendments to Outstanding Convertible Notes, including 1-Year Extension of Note Maturity Date CNW Group
Sep-11-18 07:30AM  Neovasc Announces Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule PR Newswire -15.62%
07:20AM  Neovasc Provides Initial Comments on Lawsuit CNW Group
Aug-08-18 04:48PM  Neovasc: 2Q Earnings Snapshot Associated Press +7.79%
04:05PM  Neovasc Announces Second Quarter 2018 Financial Results PR Newswire
03:19PM  What Does Neovasc Incs (TSE:NVCN) Ownership Structure Look Like? Simply Wall St.
02:30PM  Neovasc Inc. to Host Earnings Call ACCESSWIRE
01:35PM  Neovasc Announces Updated Presentation Time at the 38th Annual Canaccord Genuity Growth Conference PR Newswire
Aug-06-18 10:20AM  Biotechnology Stocks Trending on New Developments 2018 ACCESSWIRE +16.91%
07:30AM  Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology PR Newswire
07:30AM  Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology CNW Group
07:20AM  Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference PR Newswire
07:20AM  Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference CNW Group
Aug-03-18 05:34PM  Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group CNW Group
Aug-02-18 07:30AM  Neovasc Announces Second Quarter 2018 Financial Results Conference Call and Webcast CNW Group
Jul-20-18 07:00AM  Todays Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks ACCESSWIRE
Jul-16-18 04:30PM  Nasdaq Schedules Hearing to Consider Neovasc's Appeal of Delisting Determination PR Newswire
04:30PM  Nasdaq Schedules Hearing to Consider Neovasc's Appeal of Delisting Determination CNW Group
07:00AM  Neovasc Announces Filing of "Administrative" Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement CNW Group
Jul-09-18 07:00AM  Neovasc Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing PR Newswire
Jul-02-18 07:35AM  Tiara and Reducer Featured at CSI Frankfurt 2018 CNW Group
07:30AM  Neovasc Announces Filing of Shelf Prospectus and Form F-10 Registration Statement PR Newswire
Jun-27-18 05:42AM  Should You Snap up Medical Device Stock Neovasc Now? Investopedia
Jun-21-18 04:30PM  Tiara Featured in Live Case at 11th Annual TVT 2018 PR Newswire
Jun-20-18 07:30AM  Neovasc Announces First Implant of a Neovasc Reducer in a U.S. Patient CNW Group +20.32%
Jun-18-18 07:05AM  Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desks Radar ACCESSWIRE
Jun-11-18 07:30AM  Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update PR Newswire +7.84%
Jun-07-18 06:50AM  Loss-Making Neovasc Inc (NASDAQ:NVCN) Expected To Breakeven Simply Wall St.
Jun-04-18 05:38PM  Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders CNW Group +7.62%
May-25-18 07:30AM  Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer CNW Group -14.44%
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.